Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03029143
Brief Title: Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis (ENTERPRET)

First Submitted : January 20, 2017
First Submitted that Met QC Criteria : January 20, 2017
First Posted : January 24, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : January 9, 2020
Last Update Posted : January 13, 2020